Publications Sign-Up

Publications Search

Your search criteria matched 51 items:

Subject Matter Eligibility for Biotechnology Patents in the United States
Z. Ying Li, Ph.D., Siew Yen Chong, Ph.D.
September 29, 2017, Bloomberg BNA’s Life Sciences Law & Industry Report
"US Supreme Court Decisions Renew Need for Opinions on Competitor's Patents," August 4, 2017
Roger W. Parkhurst
Current Trends In Biologics-Related Inter Partes Reviews
John J. Molenda, Ph.D., Richard Praseuth
July 20, 2017, Law360
Strategic Considerations From IPR Estoppel Cases
Vishal C. Gupta, Ryann M. Muir, Ph.D.
June 7, 2017, Law360
Patent Litigation Means Teaching Hypertechnical Topics
William F. Abrams
January 17, 2017, Daily Journal
The Glow of Halo
Vishal C. Gupta, David L. Hecht
Federal Circuit Bar Association
August 15, 2016
AIA Post-Grant Proceedings: Broadest Reasonable Interpretation Standard in IPR Upheld by Supreme Court
Harold H. Fox, Ph.D.
June 20, 2016
Preparing For Discovery And Witness Selection At The ITC
Matthew N. Bathon
May 13, 2016, Law360
AIA Post-Grant Proceedings: Summary of the New AIA Review Rules
John Caracappa, David L. Hecht
April 1, 2016
Tell Me Everything: Communications Between Applicants and Non-Attorney Patent Agents Are Now Privileged
Matthew N. Bathon, Harold H. Fox, Ph.D.
March 18, 2016
AIA Post-Grant Proceedings: What Qualifies as a Printed Publication?
Harold H. Fox, Ph.D., Li Guo, Ph.D.
March 17, 2016
The Calm Before The Storm: Responding To An ITC Complaint
Steven Adkins and Matthew Bathon
February 2, 2016, Law360
Searching for a Better Constitutional Guarantor for FRE 413–415: The Conflicts Among Circuits in Applying FRE 403 Balancing Test and a New Solution
Fang Bu
2016, University of Illinois Law Review
AIA Post-Grant Proceedings: PTAB Claim Construction Does Not Bind District Court
Harold H. Fox, Ph.D., David L. Hecht
December 28, 2015
AIA Post-Grant Proceedings: Considerations in PTAB Appeals at the Federal Circuit
Harold H. Fox, Ph.D.
December 8, 2015
AIA Post-Grant Proceedings: Economic Motives of IPRs are not an “Abuse of Process”
David L. Hecht
November 4, 2015
How Congress Plans to Reel in Bass
John L. Abramic
October 5, 2015, Life Sciences Intellectual Property Review
AIA Post-Grant Proceedings: What is Required for Standing in a CBM Review?
Stanley A. Schlitter
August 21, 2015
AIA Post-Grant Proceedings: Recent Proposed Rules Have Potential to Provide Patent Owners Additional Edge
Harold H. Fox, Ph.D., Gretchen P. Miller
August 21, 2015
AIA Post-Grant Proceedings: IPR Claim Construction Update: “Broadest Reasonable Interpretation” Here to Stay - at Least for Now
Harold H. Fox, Ph.D.
August 6, 2015
AIA Post-Grant Proceedings: Motions for Additional Discovery: Surgical Strike Acquires Sought-After Document
Harold H. Fox, Ph.D.
August 5, 2015
Combating a Petition for CBM Review on Section 101 Grounds
Stanley A. Schlitter
June 18, 2015, ABA’s Intellectual Property Litigation Section Newsletter
AIA Post-Grant Proceedings: Federal Circuit’s First Reversal of PTAB in AIA Review
Harold H. Fox, Ph.D., Gretchen P. Miller
June 17, 2015
AIA Post-Grant Proceedings: Reverse Monetization Brings New Faces to the PTAB
Harold H. Fox, Ph.D., David L. Hecht
June 12, 2015
AIA Post-Grant Proceedings: Scope Of District Court Estoppel Arising From IPR
Harold H. Fox, Ph.D., Katherine Johnson
May 29, 2015
AIA Post-Grant Proceedings: Privy in IPR: What is the Relevant Time Frame?
Harold H. Fox, Ph.D., Li Guo, Ph.D.
April 15, 2015
AIA Post-Grant Proceedings: Burden on Petitioner for Establishing Earlier Prior Art Reference Dates
Douglas R. Peterson, Stanley A. Schlitter
September 29, 2014
AIA Post-Grant Proceedings: Does BRI Apply to Expired Patents?
Thomas J. Filarski
May 7, 2014
AIA Post-Grant Proceedings: PTAB Reinforces ‘Single Voice’ Position
John Caracappa
April 1, 2014
AIA Post-Grant Proceedings: PTAB Is Unable To Cancel Patent Claims It Finds Indefinite
John Caracappa, Douglas R. Peterson
March 19, 2014
AIA Post-Grant Proceedings: Multiple Petitioners Filing A Single Petition Must Present Their Case With A 'Single Voice'
John Caracappa
February 14, 2014
AIA Post-Grant Proceedings: Parties Should Consider Their Need for Video Deposition Testimony Early to Avoid Being Precluded From Introducing It Later in the Proceeding
Stanley A. Schlitter
January 16, 2014
AIA Post-Grant Proceedings: All Is Not Lost For Patent Owner After The First Written Decision In An IPR Favoring Petitioner
Douglas R. Peterson
December 20, 2013
AIA Post-Grant Proceedings: Joint Motion to Terminate May Not Stop the Board from Proceeding to a Final Written Decision
Harold H. Fox, Ph.D.
November 19, 2013
AIA Post-Grant Proceedings: Reexamination Does Not Reset The One-Year Deadline For Filing An Inter Partes Review
Harold H. Fox, Ph.D.
November 15, 2013
AIA Post-Grant Proceedings: The PTAB Draws a Hard Line Limiting Oral Argument and Demonstratives at the Final Oral Hearing
Thomas J. Filarski, Harold H. Fox, Ph.D.
November 7, 2013
AIA Post-Grant Proceedings: Uncertainty Regarding The Scope Of “Privy” And “Real Parties-In-Interest” In AIA Proceedings Remains
Harold H. Fox, Ph.D.
November 1, 2013
Design Patents: Underutilized?
2013
Even Vt. Hasn't Done Enough To Challenge 'Patent Trolls'
John Hanley
May 29, 2013, Law360
The Evolving Patent Troll
2013
Intellectual Property Advisory: Effective Timeline for the America Invents Act
Douglas R. Peterson
November 4, 2011
"All Change for US Patents?"
IAM 250: The World's Leading Patent & Technology Licensing Lawyers 2011/2012
Tom Filarski
Intellectual Asset Management
Patent Law Creates a First-to-Disclose System
Robert L. Kovelman and Douglas R. Peterson
September 27, 2011, Daily Journal
Patent Bill: Only Time Will Tell If Congress Got It Right
Robert L. Kovelman and Douglas R. Peterson
September 9, 2011, Daily Journal
America Invents Act Revamps US Patent Law
Douglas R. Peterson
September 1, 2011
Intellectual Property Advisory - Patentability of Methods Generally Upheld
John Caracappa, Harold Fox, Tremayne Norris
June 29, 2010
Intellectual Property Advisory - Recent Bills (Re)Introduced in Congress Directed to Pharmaceutical Companies
Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
March 30, 2009
Intellectual Property Advisory - FDA Denies 30-Month Stay of Approval of Certain ANDAs Under the QI-Act
Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
March 23, 2009
Intellectual Property Advisory - Amendments to Chinese Patent Law Affecting Pharmaceutical and Biotech Companies
Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
February 16, 2009
Intellectual Property Advisory - New Requirements for Submission of Bioequivalence Data for Generic Drug Applications
Harold H. Fox, Timothy C. Bickham, and William Z. Nakhleh
January 28, 2009
Litigating the Business Method Patent: Pitfalls for Unwary Defendants
William G. Pecau
2006, The Intellectual Property Strategist Vol 12 No 12

View All Current Publications | View Archived Publications